Crossmark

Quantitative assessment of baseline imbalances in evolocumab and alirocumab trials: a meta-epidemiological study

Published Online: 2024-06-22

Authors

van Bruggen, F. H.

Zuidema, S. U.

Luijendijk, H. J.
License Information

Text and Data Mining valid from 2024-06-22

Version of Record valid from 2024-06-22
More Information

Article History

Received: 17 July 2023

Accepted: 7 June 2024

First Online: 22 June 2024

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current